Inventor
AUDREY GODDARD
Inventor
US
Overview
Patents· 5 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
G16Bprimary
G16BBioinformatics, i.e. information and communication technology [ict] specially adapted for genetic or protein-related data processing in computational molecular biology23%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms18%
G16HHealthcare informatics, i.e. information and communication technology [ict] specially adapted for the handling or processing of medical or healthcare data18%
G01NInvestigating or analysing materials by determining their chemical or physical properties9%
G06NComputing arrangements based on specific computational models9%
Y02ATechnologies for adaptation to climate change9%
C12NMicroorganisms or enzymes5%
G16CComputational chemistry5%
G16ZInformation and communication technology [ict] specially adapted for specific application fields, not otherwise provided for5%
PatentTitleYear
12,412,642Method to use gene expression to determine likelihood of clinical outcome of renal cancer202511,783,914Method and system for panel characterizations202311,776,664Method to use gene expression to determine likelihood of clinical outcome of renal cancer202311,572,555Method and system for CRISPR-based library preparation and sequencing202311,551,782Gene expression profile algorithm for calculating a recurrence score for a patient with kidney cancer2023Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2023–2025Patents assigned to GENOMIC HEALTH INC (3)· patent assignee history
2023Patents assigned to PSOMAGEN INC (2)· patent assignee history
2023–2025Based in US· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| GENOMIC HEALTH INC | 3 | 2023–2025 |
| PSOMAGEN INC | 2 | 2023 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 5 | 2023–2025 |